Page last updated: 2024-11-02

pioglitazone and Cicatrix

pioglitazone has been researched along with Cicatrix in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Cicatrix: The fibrous tissue that replaces normal tissue during the process of WOUND HEALING.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
O'Leary, R1
Ponnambalam, S1
Wood, EJ1

Other Studies

1 other study available for pioglitazone and Cicatrix

ArticleYear
Pioglitazone-induced myofibroblast cell death: implications for cutaneous scarring.
    The British journal of dermatology, 2003, Volume: 149, Issue:3

    Topics: Cell Death; Cell Survival; Cells, Cultured; Cicatrix; Fibroblasts; Humans; Hypoglycemic Agents; Musc

2003